carbachol (miostat) Report issue

Small molecule Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Carbachol is a potent cholinergic (parasympathomimetic) agent which produces constriction of the iris and ciliary body resulting in reduction in intraocular pressure.   NCATS

Chemistry

  • SMILES: C[N+](C)(C)CCOC(=O)N
  • InChIKey: VPJXQGSRWJZDOB-UHFFFAOYSA-O
  • Mol. Mass: 147.2
  • ALogP: -0.21
  • ChEMBL Molecules:
    carbachol  
    carbachol  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$2.9400 - $4.2650
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

2-((aminocarbonyl)oxy)-n,n,n-trimethylethanaminium chloride | 2-((aminocarbonyl)oxy)-n,n,n-trimethylethanaminum chloride | (2-carbamoyloxyethyl)trimethylammonium chloride | (2-hydroxyethyl)trimethyl ammonium chloride carbamate | (2-hydroxyethyl)trimethylammonium chloride carbamate | carbachol | carbachol chloride | carbacholine chloride | carbacholum | carbacol | carbaminoylcholine chloride | carbamoylcholine chloride | carbamylcholine | carbastat | carboptic | choline carbamate chloride | choline chloride, carbamate | choline chlorine carbamate | doryl | isopto carbachol | karbachol | karbamoylcholin chlorid | miostat

Organizations (5)

Research & Development (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (2)


 

Glaucoma

Intraocular Pressure (approved 1972)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Presbyopia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial Organizations: 2

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue